Valuation: Jamjoom Pharmaceuticals Factory Company

Market Cap 9.46B 2.52B 2.2B 2.07B 1.88B 3.53B 242B 3.54B 24.83B 9.58B 123B 9.25B 395B P/E 2026 *
19.5x
P/E 2027 * 17.6x
Enterprise Value 9.14B 2.43B 2.12B 2B 1.82B 3.41B 233B 3.42B 24B 9.26B 119B 8.94B 382B EV / Sales 2026 *
5.56x
EV / Sales 2027 * 4.94x
Free-Float
38.61%
Yield 2026 *
3.1%
Yield 2027 * 3.51%

Last Transcript: Jamjoom Pharmaceuticals Factory Company

1 day+3.92%
1 week-1.53%
Current month-1.31%
1 month-3.08%
3 months-17.42%
6 months-2.95%
Current year-5.06%
1 week 129.1
Extreme 129.1
136.8
1 month 129.1
Extreme 129.1
143.5
Current year 125
Extreme 125
163.7
1 year 125
Extreme 125
165.3
3 years 100.2
Extreme 100.2
202.4
5 years 66
Extreme 66
202.4
10 years 66
Extreme 66
202.4
Manager TitleAgeSince
Chief Executive Officer 62 15/05/2021
Director of Finance/CFO 62 13/01/2013
Chief Operating Officer 31 01/09/2021
Director TitleAgeSince
Director/Board Member - 19/06/2022
Chairman 66 19/06/2022
Director/Board Member 41 19/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
+3.92%-1.53%-11.12%+19.14% 2.52B
-1.61%-0.15%+11.45%+60.09% 45.94B
-1.02%-1.90%+35.99%+100.50% 37.22B
+2.19%+3.65%+10.70%+80.29% 12.06B
+1.32%+2.09%-11.64%+12.41% 11.74B
-0.95%0.00%+18.72%+150.00% 9.03B
+0.39%+2.39%+29.99%+38.63% 7.36B
-0.06%+2.97%+38.90%-18.67% 7.15B
+1.30%+1.17%+16.08%+187.41% 7.2B
+0.70%+1.10%-44.22%+5.78% 5.03B
Average +0.62%+0.82%+9.48%+63.56% 14.52B
Weighted average by Cap. -0.37%+0.19%+16.46%+72.61%

Financials

2026 *2027 *
Net sales 1.64B 437M 381M 360M 327M 613M 41.97B 615M 4.31B 1.66B 21.34B 1.61B 68.66B 1.83B 488M 426M 402M 365M 684M 46.84B 687M 4.81B 1.86B 23.81B 1.79B 76.62B
Net income 487M 130M 113M 107M 96.93M 182M 12.44B 182M 1.28B 493M 6.32B 476M 20.35B 536M 143M 124M 117M 107M 200M 13.69B 201M 1.41B 543M 6.96B 524M 22.4B
Net Debt -317M -84.39M -73.59M -69.48M -63.09M -118M -8.1B -119M -832M -321M -4.12B -310M -13.25B -404M -108M -93.78M -88.55M -80.41M -151M -10.32B -151M -1.06B -409M -5.25B -395M -16.88B
Logo Jamjoom Pharmaceuticals Factory Company
Jamjoom Pharmaceuticals Factory Company is a Saudi Arabia-based entity which is primarily engaged in manufacturing, production, marketing, and distribution of pharmaceutical products. The Company is organized into two segments which are pharmaceutical products, consumer health products. pharmaceutical products represents medicines or drugs and they are essential for the prevention and treatment of diseases, and protection of public health; consumer health products represents products used to support personal well-being, maintain health, or address specific health-related needs. The activities of the company include producing human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer and acidity, treatment of various skin infections, cancer diseases, eye drops and ointments and cosmeceuticals. The Company operates approximately 7 branches in Saudi Arabia.
Employees
-
Date Price Change Volume
17/09/26 SAR 135.10 +3.92% 220,864
16/09/26 SAR 130.00 -1.29% 48,164
15/09/26 SAR 131.70 -2.23% 41,633
14/09/26 SAR 134.70 -1.03% 57,048
13/09/26 SAR 136.10 -0.80% 6,827
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
135.10SAR
Average target price
154.68SAR
Spread / Average Target
+14.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4015 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!